AGP Picks
View all

Oman Technology Reporter: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Oman Technology Reporter.

Press releases published on June 16, 2026

CDT Equity Announces Debt Update and New Loan Facility
Airia Named Winner of AI Governance Platform Award in 2026 Cybersecurity Stars Awards
Aptean übernimmt ROTOR - Erweitert sein Angebot an Dealer-Management-Systemen
Aptean Acquires ROTOR - Expands Its Dealer Management Systems Offerings
Opti9 Technologies Named Exclusive North American Distributor for Virtuozzo
VivoPower’s B Corporation Recertification Strengthens Its Sovereign Infrastructure Mandate; Tembo Qualified to Use B Corp Logo
Bond Announces Conversion of Outstanding Debt into Equity at Significant Premium to Market
AmMax Bio Names Biopharmaceutical Executive Travis Read as President and Chief Operating Officer
Outlook Therapeutics Announces FDA Acceptance of Resubmitted Biologics License Application for ONS-5010/LYTENAVA™ (bevacizumab-vikg) as a Treatment for Wet AMD
Adherent Launches Agentic AI Platform for Product Compliance
RTI Achieves CMMC Level 2 Certification to Support Mission-Critical Defense Programs
10 Seconds per Traveler: Regula and RADEX BСMS Win Award for Transforming Border Control Efficiency
ConSynance Therapeutics Announces First Patient Dosed in Phase 2a Clinical Trial of CSTI-500 for Prader-Willi Syndrome
VisionWave Holdings Signs Term Sheet for a Proposed Tier IV Data Center Joint Venture with Lucky Whale Production Limited
ROC Appoints Federal Law Enforcement Veteran Dr. Kathleen Kiernan to Board of Directors
BigCommerce Earns 2026 Top Rated Award From TrustRadius
Syncromune Presents Multi-Modal Efficacy Assessment Framework at Inaugural Gustave Roussy Intratumoral Immunotherapy Symposium
VitalEdge Technologies Appoints Former Hitachi Construction Machinery Americas CEO Alan Quinn to Board of Directors
Point Predictive Introduces IEValidate® True Income and Employment, the Unrivaled Advancement in Employment Verification
BioAge Labs Announces First Participant Dosed in QUELL-CV, a Phase 2 Proof-of-Concept Trial of BGE-102, a Novel Oral NLRP3 Inhibitor, in Patients at Elevated Cardiovascular Risk

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Oman Technology Reporter

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.